KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Invested Capital (2019 - 2025)

Historic Invested Capital for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $1.1 billion.

  • GoodRx Holdings' Invested Capital fell 824.66% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 824.66%. This contributed to the annual value of $1.2 billion for FY2024, which is 1424.65% down from last year.
  • Per GoodRx Holdings' latest filing, its Invested Capital stood at $1.1 billion for Q3 2025, which was down 824.66% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Invested Capital ranged from a high of $1.6 billion in Q2 2023 and a low of $756.1 million during Q1 2021
  • Over the past 5 years, GoodRx Holdings' median Invested Capital value was $1.1 billion (recorded in 2025), while the average stood at $1.1 billion.
  • As far as peak fluctuations go, GoodRx Holdings' Invested Capital soared by 18097.74% in 2021, and later plummeted by 2272.26% in 2024.
  • Over the past 5 years, GoodRx Holdings' Invested Capital (Quarter) stood at $838.7 million in 2021, then soared by 75.7% to $1.5 billion in 2022, then decreased by 3.75% to $1.4 billion in 2023, then fell by 14.25% to $1.2 billion in 2024, then fell by 10.4% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.